IFNAR1 and melanoma: Specific deletion of IFNAR in Tregs results in increased Treg proliferation and higher expression of PD-1 and CD44 on their cell surface, leading to decreased anti-tumor immune responses and tumor clearing in mouse models of colon cancer and melanoma [122].